Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button

Home > Press > Gold Nanomedicine Clinical Trial Delivers Promising Results

Abstract:
Novel Approach in Cancer Therapy at the Forefront of Gold-Based Medical Applications

Gold Nanomedicine Clinical Trial Delivers Promising Results

London | Posted on December 24th, 2010

The World Gold Council (WGC) is delighted with the successful phase 1 clinical trial of a unique nanomedicine that uses nanoparticles of gold as the core of a delivery system for tumour targeted drug delivery. The research, published in the current edition of Clinical Cancer Research, was carried out by US-based life sciences company CytImmune Sciences Inc.

CytImmune's technology is at the forefront of a raft of gold-based innovations as described earlier this year by the WGC in a paper entitled 'Gold for Good: Gold and nanotechnology in the age of innovation'. The report demonstrates how gold nanoparticles exhibit a variety of unique properties which are showing great potential in a range of fields.

Dr Richard Holliday, Director, Technology at the WGC said: "Gold has a long history in the biomedical field, being the material of choice in many diagnostic platforms and a key constituent for rheumatoid arthritis treatment. The dawn of the 'nano-age' has further broadened the potential of gold in biomedical applications and it is exciting to see the outcome of this clinical trial which suggests that gold can act as an effective and safe drug delivery system."

In medicine, gold nanoparticles can serve as a simple, elegant platform upon which potent therapies may be bound. In this clinical trial the nanoparticles, which were coated with both an immune-avoiding molecule and a potent anti-cancer agent, were shown to be very well tolerated and to target solid tumours. There is hope that such targeting technology will be effective against a range of cancers, including lung, pancreatic, breast and ovarian cancer.

Dr Lawrence Tamarkin, CEO of CytImmune Sciences Inc. said: "This phase 1 clinical study potentially marks the beginning of a new strategy in cancer treatment where gold nanoparticle-based cancer therapeutics are used first, before surgery, to reduce tumour burden. Reducing tumour size may require less sophisticated surgeries to remove any residual tumour, leading to shorter hospital stays and to improved patient outcomes. Phase 2 clinical studies will prove the value of this novel drug delivery platform."

Dr Holliday continued: "By continuously reviewing and monitoring the global research landscape in gold science and technology, we are able to identify and, where appropriate, help accelerate the time to market key, new technologies that have social, environmental or medical benefits."

####

For more information, please click here

Copyright © World Gold Council

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Novel state of matter: Observation of a quantum spin liquid July 29th, 2016

A new type of quantum bits July 29th, 2016

Lonely atoms, happily reunited July 29th, 2016

Penn team uses nanoparticles to break up plaque and prevent cavities July 28th, 2016

Possible Futures

Novel state of matter: Observation of a quantum spin liquid July 29th, 2016

A new type of quantum bits July 29th, 2016

Dirty to drinkable: Engineers develop novel hybrid nanomaterials to transform water July 28th, 2016

Penn team uses nanoparticles to break up plaque and prevent cavities July 28th, 2016

Nanomedicine

Pixel-array quantum cascade detector paves the way for portable thermal imaging devices: Research team from TU-Wien Center for Micro- and Nanostructures have developed a new 'cooler' sensing instrument thereby increasing energy-efficiency and enhancing mobility for diagnostic tes July 28th, 2016

Starpharma initiates new DEP™ drug delivery program with AstraZeneca July 27th, 2016

Scientists test nanoparticle drug delivery in dogs with osteosarcoma July 26th, 2016

The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins July 26th, 2016

Announcements

Novel state of matter: Observation of a quantum spin liquid July 29th, 2016

A new type of quantum bits July 29th, 2016

Lonely atoms, happily reunited July 29th, 2016

Pixel-array quantum cascade detector paves the way for portable thermal imaging devices: Research team from TU-Wien Center for Micro- and Nanostructures have developed a new 'cooler' sensing instrument thereby increasing energy-efficiency and enhancing mobility for diagnostic tes July 28th, 2016

Nanobiotechnology

Starpharma initiates new DEP™ drug delivery program with AstraZeneca July 27th, 2016

Scientists test nanoparticle drug delivery in dogs with osteosarcoma July 26th, 2016

Accurate design of large icosahedral protein nanocages pushes bioengineering boundaries: Scientists used computational methods to build ten large, two-component, co-assembling icosahedral protein complexes the size of small virus coats July 25th, 2016

New remote-controlled microrobots for medical operations July 23rd, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic